Altesa BioSciences: Valuation, Funding & Investors
A clinical-stage pharmaceutical company focused on developing therapies for chronic lung diseases, including COPD and asthma. The company is advancing novel antiviral and respiratory treatments aimed at reducing respiratory exacerbations and improving patient outcomes.
Leadership & Board
- Current Number of Employees
- 21
- Current LinkedIn Followers
- 2,310
Latest Estimated Valuation
- Total Amount Raised
- $75M
- Total Funding Rounds
- 1
- Latest Funding Amount
- $75M
- Latest Funding Round
- Series B
Employee Trend
Altesa BioSciences had 21 employees as of November 16, 2026. The number of employees increased by 0 (0.00%) week-over-week.
21Latest Employee Count
0(0.00%)Week-Over-Week Change
Social Trend
Altesa BioSciences had 2,310 followers as of November 16, 2026. The number of followers increased by 5 (0.22%) week-over-week.
2,310Latest Followers Count
5(0.22%)Week-Over-Week Change
Funding Round
| Funding Date | Funding Round | Amount Raised | Post-Money Valuation |
|---|---|---|---|
| Feb 19, 2026 | Series B | $75.00M | ― |
Investors
| Investor Name | Funding Round |
|---|---|
| Atlantic Partners | Series B |
| Forbion | Series B |
| Medicxi | Series B |
| Pitango | Series B |
| Sanofi | Series B |
Similar Companies
A snapshot of private companies similar to Altesa BioSciences, helping you discover and navigate related company profiles.
Related News and Analysis







